Scientia Vascular
Generated 5/10/2026
Executive Summary
Scientia Vascular is a private neurovascular medical device company headquartered in West Valley City, Utah, founded in 2014. The company is focused on developing advanced treatment systems for neurovascular conditions, aiming to redefine standards of care in the field. With a track record of growth and innovation, Scientia Vascular is positioned to address significant unmet needs in neurovascular intervention, particularly in areas such as stroke and aneurysm treatment. While specific product details and financials are not publicly disclosed, the company's emphasis on cutting-edge technology and its location in a key medical device hub suggest strong potential for commercialization and market penetration. Scientia Vascular's ability to secure regulatory approvals and build a robust pipeline will be critical for its success in a competitive landscape dominated by larger players.
Upcoming Catalysts (preview)
- Q3 2026New Product Launch or FDA Clearance65% success
- Q4 2026Positive Clinical Trial Results55% success
- Q2 2026Strategic Partnership or Distribution Agreement70% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)